RE:RE:New investors from the dealWhatever makes the most sense from a funding standpoint but I was thinking half a warrant for each share owned just like the new shareholders got. That would raise about $122 million if fully exercised in addition to the $27 million additional funds coming in from the warrants from the deal.
Obviously the terms could be adjusted (for example a lower exercise price) of the company does not want to raise quite that mich money but my guess is there is a good chance they will need it.
Now, there are no doubt all sorts of problems with this idea from a regulatory perspective. But if they can be worked around, and usually they can, why not do it?
JayjayUSA12007 wrote:
SPCEO: "I have an idea for the company to consider. It would seem fait to me if the company granted outright to all current shareholders the same warrant they just sold to the new investors."
That would be a good idea and fair. After all, Thera still needs more money to further its clinical trials.
Would the number of warrants granted to existing shareholders be proportional to their current holdings ?